Membrane proteins represent a great potential in drug discovery.
Yet, despite 60% of FDA-approved drugs targeting these proteins, less than 2% have been structurally characterized, due to their challenging nature.
To support membrane protein researchers, Cube Biotech and NanoTemper offer technologies and instruments that maintain membrane protein stability and allow studies in their natural lipid environment. These tools enable you to efficiently identify new drug targets while preserving protein functionality.
In this webinar Dr. Philipp Hanisch shares his insights on how to best address solubilization and characterization challenges of membrane proteins, with practical tips.
Watch it to learn about:
- NativeMP™ Copolymer Technology: With a range of copolymers at its core, the technology provides a detergent-free solution, that stabilizes membrane proteins in their native lipid environment and allows it to be studied in its fully functional state.
- A multi-parameter tool to efficiently screen for the optimal copolymer that stabilize your membrane proteins in any buffer: Prometheus Panta.
- A biophysical tool for affinity characterization – Monolith X – to study membrane protein drug targets in their natural lipid environment.
Get more resources on membrane proteins here.
